New Study Evaluated Impact on Chronic Ocular Disease, Including Age-Related Macular Degeneration A retrospective cohort study scheduled for publication in Ophthalmology , the journal of the American Academy of Ophthalmology, investigated whether GLP-1 agonists influence the risk for age-related ocular diseases such as age-related macular degeneration (AMD), cataracts, and glaucoma, in an at-risk population
It does not alter urinary glucose levels
## Combining Semaglutide with Supportive Therapies One advantage of transitioning from AOD-9604 to a GLP-1 **weight loss peptide** is the ability to complement the protocol with well-studied supportive therapies: ### NAD+ for Metabolic and Anti-Aging Support [NAD+ injections](/guides/nad-injection-benefits-anti-aging-energy-recovery-guide) support mitochondrial function, cellular energy production, and DNA repair all of which may be beneficial during active **fat loss**
In the liver , it binds to toxins, alcohol byproducts, heavy metals, and environmental chemicals so the body can process and clear them safely
